Work

Clinical outcomes with ERBB2 gene amplification and activating mutations in muscle-invasive bladder cancer patients treated with neoadjuvant chemotherapy.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4595

Authors: Earle F. Burgess, Landon Carter Brown, Michael Joseph McCormack, Ericson Stoen, Metamia Ciampricotti, Edward Williams, James Thomas Symanowski

Institutions: Wake Forest Baptist Comprehensive Cancer Center, Tempus Labs (United States)

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Atrium Health Foundation

OpenAlex ID: W7162562316

Cites:

Cited by:

Related to: